Sunday, October 19, 2014

Trans Pacific Partnership Update


Press Release — Updated Secret Trans-Pacific Partnership Agreement (TPP) — IP Chapter (second publication)
Posted on October 19, 2014 Written by wikileaks.org
Thurs­day 16 Octo­ber 2014, Wik­iLeaks released a sec­ond updated ver­sion of the Trans-Pacific Part­ner­ship (TPP) Intel­lec­tual Prop­erty Rights Chap­ter. The TPP is the world’s largest eco­nomic trade agree­ment that will, if it comes into force, encom­pass more than 40 per cent of the world’s GDP. The IP Chap­ter cov­ers top­ics from phar­ma­ceu­ti­cals, patent reg­is­tra­tions and copy­right issues to dig­i­tal rights. Experts say it will affect free­dom of infor­ma­tion, civil lib­er­ties and access to med­i­cines glob­ally. The Wik­iLeaks release comes ahead of a Chief Nego­tia­tors’ meet­ing in Can­berra on 19 Octo­ber 2014, which is fol­lowed by what is meant to be a deci­sive Min­is­te­r­ial meet­ing in Syd­ney on 25–27 October.
Despite the wide-ranging effects on the global pop­u­la­tion, the TPP is cur­rently being nego­ti­ated in total secrecy by 12 coun­tries. Few peo­ple, even within the nego­ti­at­ing coun­tries’ gov­ern­ments, have access to the full text of the draft agree­ment and the pub­lic, who it will affect most, none at all. Large cor­po­ra­tions, how­ever, are able to see por­tions of the text, gen­er­at­ing a pow­er­ful lobby to effect changes on behalf of these groups and bring­ing devel­op­ing coun­try mem­bers reduced force, while the pub­lic at large gets no say. Julian Assange, Wik­iLeaks’ Editor-in-Chief, said:
The selec­tive secrecy sur­round­ing the TPP nego­ti­a­tions, which has let in a few cashed-up mega­corps but excluded every­one else, reveals a telling fear of pub­lic scrutiny. By pub­lish­ing this text we allow the pub­lic to engage in issues that will have such a fun­da­men­tal impact on their lives.
The 77-page, 30,000-word doc­u­ment is a work­ing doc­u­ment from the nego­ti­a­tions in Ho Chi Minh City, Viet­nam, dated 16 May 2014, and includes negotiator’s notes and all coun­try posi­tions from that period in brack­eted text. Although there have been a cou­ple of addi­tional rounds of talks since this text, lit­tle has changed in them and it is clear that the nego­ti­a­tions are stalling and that the issues raised in this doc­u­ment will be very much on the table in Aus­tralia this month.
The last time the pub­lic got access to the TPP IP Chap­ter draft text was in Novem­ber 2013 when Wik­iLeaks pub­lished the 30 August 2013 brack­eted text. Since that point, some con­tro­ver­sial and dam­ag­ing areas have had lit­tle change; issues sur­round­ing dig­i­tal rights have moved lit­tle. How­ever, there are sig­nif­i­cant industry-favouring addi­tions within the areas of phar­ma­ceu­ti­cals and patents. These addi­tions are likely to affect access to impor­tant med­i­cines such as can­cer drugs and will also weaken the require­ments needed to patent genes in plants, which will impact small farm­ers and boost the dom­i­nance of large agri­cul­tural cor­po­ra­tions like Monsanto.
Nev­er­the­less, some areas that were high­lighted after Wik­iLeaks’ last IP Chap­ter release have seen alter­ations that reflect the con­tro­versy; sur­gi­cal method patents have been removed from the text. Doc­tors’ groups said this was vitally impor­tant for allow­ing doc­tors to engage in med­ical pro­ce­dures with­out fear of a law­suit for pro­vid­ing the best care for their patients. Oppo­si­tion is increas­ing to remove the pro­vi­sion pro­posed by the US and Japan that would require grant­ing of patents for new drugs that are slightly altered from a pre­vi­ous patented one (ever­green­ing), a tech­nique by the phar­ma­ceu­ti­cal indus­try to pro­long mar­ket monopoly.
The new Wik­iLeaks release of the May 2014 TPP IP text also has pre­vi­ously unseen adden­dums, includ­ing a new pro­posal for dif­fer­ent treat­ment for devel­op­ing coun­tries, with vary­ing tran­si­tion peri­ods for the text to take force. Whilst this can be viewed as an attempt to ease the onus of this harsh treaty on these coun­tries, our diplo­matic sources say it is a stalling tac­tic. The neg­a­tive pro­pos­als within the agree­ment would still have to come into force in those coun­tries, while the gov­ern­ments that brought them in would have changed.
Despite the United States want­ing to push to a res­o­lu­tion within the TPP last year, this brack­eted text shows there is still huge oppo­si­tion and dis­agree­ment through­out the text. At this crit­i­cal moment the nego­ti­a­tions have now stalled, and devel­op­ing coun­tries are giv­ing greater resis­tance. Despite the huge lob­by­ing efforts, and many favourable pro­pos­als for big phar­ma­ceu­ti­cal com­pa­nies, they are not get­ting entirely what they wish for either. Julian Assange said:
The lack of move­ment within the TPP IP Chap­ter shows that this only stands to harm peo­ple, and no one is sat­is­fied. This clearly demon­strates that such an all-encompassing and divi­sive trade agree­ment is too dam­ag­ing to be brought into force. The TPP should stop now.
Cur­rent TPP nego­ti­a­tion mem­ber states are the United States, Japan, Mex­ico, Canada, Aus­tralia, Malaysia, Chile, Sin­ga­pore, Peru, Viet­nam, New Zealand and Brunei.
 
 

No comments: